Want to join the conversation?
$NEM 2Q15 PR: Diluted EPS $0.14 vs. $0.36 in 2Q14. Declared dividend of $0.025 per share. Paid $75MM towards project debt facilities. YTD, paid $200MM toward existing term loan & $80MM toward project debt in Ghana and Indonesia. Free cash flow from continuing operations were $119MM vs. $124MM in 2Q14. 2Q15-end cash & cash equivalents were $3308MM.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)